Founded in 2010, Cryogatt is a privately funded company dedicated to the development and deployment of cutting-edge RFID systems that assist in the tracking of critical assets under extreme temperature, reliably operating between room temperature and -196°C.
Cryogatt commissioned the research into development and delivery of RFID tags that could be sterilised and inserted into disposables at the manufacturing stage; and ensured that these tags would work in the very low temperature environment. Cryogatt Systems is the only company to provide this type of tag.
With the use of RFID, the Cryogatt Tagging System can now assign every asset, donor, recipient, and process outcome, to each sample and subsample.
This is no longer just about locating an asset but enhancing the quality of information being held by the asset and making the whole process of data collection, process management, SOP (standard operating procedure), and compliance accurate all of the time, through the sample’s entire “life”.
"These data strongly suggest that exposure to RFID tags at -196C has no detrimental effect on sperm motility, velocity, viability or DNA fragmentation, allowing RFID Cryogatt technology to be implemented into cryostorage procedures with confidence."
“The Rare and Imported Pathogen Laboratory (RIPL) of Public Health England (PHE), located at Porton Down UK, has installed the Cryogatt Cryogenic RFID sample archiving system to enable the electronic labelling, tracking and management of precious human sera stored in its RFID enabled vials for routine use within its laboratory. Storage is in temperatures down to -196°C. The Cryogatt system is now an integral part of the Quality Management System addressing a number of key considerations for successful laboratory accreditation. After the success of this installation, we are now looking to introduce the Cryogatt RFID technology into other Laboratories”. January 2018
"The National Institute for Biological Standards and Control (NIBSC) has been Cryogatt Systems Ltd's lead customer for its Cryo Stock Control and Audit System. It has been deployed in the Division of Advanced Therapies and we are pleased to report that in February 2014 it successfully completed product acceptance tests and staff were trained in its use. The system is used for the banking of cell lines used in the production of international biological standards and in vaccine testing. As these cell banks are stored and used over decades, reliability and longevity are essential. The system is progressively being brought into routine use. Prior to February 2014 the Cryogatt system of software, RFID readers and RFID enabled cryotubes underwent a reliability trial for 12 months, gaining reliable reading of cryotubes at -190 degC." November 2014.
